Quantitative Mapping of Substantia Nigra Iron in Parkinson's Disease (Stages I-IV, REM Sleep Behavior Disorder) and Controls

Conditions:   Parkinson Disease;   REM Sleep Behavior Disorder;   Healthy Intervention:   Drug: (11C)PE2I Sponsors:   Weill Medical College of Cornell University;   National Institute of Neurological Disorders and Stroke (NINDS) Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials